Donald Trump Drops Massive News After Latest Development From Durham Probe

President Donald J. Trump is shaking things up by predicting that recent court filings- targeting Hillary R. Clinton and her 2016 Presidential campaign by Special Counsel John Durham are “just the beginning” of what’s to come from an extremely long and somewhat mysterious investigation and series of legal actions.

CNN reported in September, explaining the battleground:

“Special counsel, John Durham’s office, is in the final stages of its closely watched investigation into potential criminal misconduct during the Trump-Russia probe, and his team is finishing up its written report, according to multiple people briefed on the matter.

The scheduled upcoming trial, against a Russian expat who was a primary source of information for the infamous Trump-Russia dossier, is set to begin next month in Alexandria, Virginia. But four weeks before trial, Durham’s case suffered a significant blow, with prosecutors acknowledging in recent court filings that they can’t convince a critical witness to return to the US to testify.”

Trump’s recent comments signal that he is feeling positive about what is about to come out, and he is preparing people that there is more to come:

https://republicbrief.com/donald-trump-drops-massive-news-after-latest-development-from-durham-probe/

US Buying $290M Worth Of Anti-Radiation Drugs for Use In "Nuclear Emergency"

The Biden regime is buying up $290 million in anti-radiation drugs for use in "nuclear emergencies" amid escalating tensions with Russia and heightened threats of a nuclear war.

FOR IMMEDIATE RELEASE

October 4, 2022

Contact HHS Press Office

202-821-9446

asprmedia@hhs.gov

www.hhs.gov/news

Twitter: @HHSgov

HHS purchases drug for use in radiological and nuclear emergencies

As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).

Amgen, based in Thousands Oaks, California, developed Nplate for ARS with support from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Administration for Strategic Preparedness and Response (ASPR), as well as the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

BARDA is using its authority provided under the 2004 Project Bioshield Act and $290 million in Project BioShield designated funding to purchase this supply of the drug. Amgen will maintain this supply in vendor-managed inventory. This approach decreases life-cycle management costs for taxpayers because doses that near expiration can be rotated into the commercial market for rapid use prior to expiry and new doses can be added to the government supply.

https://www.zerohedge.com/geopolitical/us-buying-290m-worth-anti-radiation-drugs-use-nuclear-emergency

>>17637714

This shit stain is very scared

https://lizcrokin.substack.com/p/pizzagate-exposed-part-1?r=17d7ph&utm_medium=ios

>>17637739

>>17637771

Shit stain is from msdnc so there is that. Lying to the public is what they do.

>>17637869

SAME